Literature DB >> 32270315

Diagnostic accuracy of texture analysis and machine learning for quantification of liver fibrosis in MRI: correlation with MR elastography and histopathology.

Khoschy Schawkat1,2,3, Alexander Ciritsis1,3, Caecilia S Reiner4,5, Sophie von Ulmenstein1,3, Hanna Honcharova-Biletska3,6, Christoph Jüngst3,7, Achim Weber3,6, Christoph Gubler3,7, Joachim Mertens3,7.   

Abstract

OBJECTIVES: To compare the diagnostic accuracy of texture analysis (TA)-derived parameters combined with machine learning (ML) of non-contrast-enhanced T1w and T2w fat-saturated (fs) images with MR elastography (MRE) for liver fibrosis quantification.
METHODS: In this IRB-approved prospective study, liver MRIs of participants with suspected chronic liver disease who underwent liver biopsy between August 2015 and May 2018 were analyzed. Two readers blinded to clinical and histopathological findings performed TA. The participants were categorized into no or low-stage (0-2) and high-stage (3-4) fibrosis groups. Confusion matrices were calculated using a support vector machine combined with principal component analysis. The diagnostic accuracy of ML-based TA of liver fibrosis and MRE was assessed by area under the receiver operating characteristic curves (AUC). Histopathology served as reference standard.
RESULTS: A total of 62 consecutive participants (40 men; mean age ± standard deviation, 48 ± 13 years) were included. The accuracy of TA and ML on T1w was 85.7% (95% confidence interval [CI] 63.7-97.0) and 61.9% (95% CI 38.4-81.9) on T2w fs for classification of liver fibrosis into low-stage and high-stage fibrosis. The AUC for TA on T1w was similar to MRE (0.82 [95% CI 0.59-0.95] vs. 0.92 [95% CI 0.71-0.99], p = 0.41), while the AUC for T2w fs was significantly lower compared to MRE (0.57 [95% CI 0.34-0.78] vs. 0.92 [95% CI 0.71-0.99], p = 0.008).
CONCLUSION: Our results suggest that liver fibrosis can be quantified with TA-derived parameters of T1w when combined with a ML algorithm with similar accuracy compared to MRE. KEY POINTS: • Liver fibrosis can be categorized into low-stage fibrosis (0-2) and high-stage fibrosis (3-4) using texture analysis-derived parameters of T1-weighted images with a machine learning approach. • For the differentiation of low-stage fibrosis and high-stage fibrosis, the diagnostic accuracy of texture analysis on T1-weighted images combined with a machine learning algorithm is similar compared to MR elastography.

Entities:  

Keywords:  Artificial intelligence; Elasticity imaging techniques; Liver fibrosis; Machine learning

Mesh:

Year:  2020        PMID: 32270315     DOI: 10.1007/s00330-020-06831-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  12 in total

1.  Imaging biomarkers of diffuse liver disease: current status.

Authors:  Bachir Taouli; Filipe Caseiro Alves
Journal:  Abdom Radiol (NY)       Date:  2020-06-25

2.  A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study.

Authors:  Zhong-Wei Chen; Huan-Ming Xiao; Xinjian Ye; Kun Liu; Rafael S Rios; Kenneth I Zheng; Yi Jin; Giovanni Targher; Christopher D Byrne; Junping Shi; Zhihan Yan; Xiao-Ling Chi; Ming-Hua Zheng
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

3.  Radiomics nomograms based on R2* mapping and clinical biomarkers for staging of liver fibrosis in patients with chronic hepatitis B: a single-center retrospective study.

Authors:  Die Zhang; Yi Cao; Yi Sun; Xia Zhao; Cheng Peng; Jing Zhao; Xiaohui Bao; Lifei Wang; Chen Zhang
Journal:  Eur Radiol       Date:  2022-09-23       Impact factor: 7.034

4.  Usefulness of Noncontrast MRI-Based Radiomics Combined Clinic Biomarkers in Stratification of Liver Fibrosis.

Authors:  Ru Zhao; Hong Zhao; Ya-Qiong Ge; Fang-Fang Zhou; Long-Sheng Wang; Hong-Zhen Yu; Xi-Jun Gong
Journal:  Can J Gastroenterol Hepatol       Date:  2022-06-21

Review 5.  Liver fibrosis quantification.

Authors:  Sudhakar K Venkatesh; Michael S Torbenson
Journal:  Abdom Radiol (NY)       Date:  2022-01-12

6.  Magnetic resonance quantitative susceptibility mapping in the evaluation of hepatic fibrosis in chronic liver disease: a feasibility study.

Authors:  Zheng Qu; Shuohui Yang; Feng Xing; Rui Tong; Chenyao Yang; Rongfang Guo; Jiling Huang; Fang Lu; Caixia Fu; Xu Yan; Stefanie Hectors; Kelly Gillen; Yi Wang; Chenghai Liu; Songhua Zhan; Jianqi Li
Journal:  Quant Imaging Med Surg       Date:  2021-04

7.  An Overview of Artificial Intelligence Applications in Liver and Pancreatic Imaging.

Authors:  Nicolò Cardobi; Alessandro Dal Palù; Federica Pedrini; Alessandro Beleù; Riccardo Nocini; Riccardo De Robertis; Andrea Ruzzenente; Roberto Salvia; Stefania Montemezzi; Mirko D'Onofrio
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639

8.  Deep Learning Prediction of Voxel-Level Liver Stiffness in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Brian L Pollack; Kayhan Batmanghelich; Stephen S Cai; Emile Gordon; Stephen Wallace; Roberta Catania; Carlos Morillo-Hernandez; Alessandro Furlan; Amir A Borhani
Journal:  Radiol Artif Intell       Date:  2021-09-29

Review 9.  Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

Authors:  Alexandros Marios Sofias; Federica De Lorenzi; Quim Peña; Armin Azadkhah Shalmani; Mihael Vucur; Jiong-Wei Wang; Fabian Kiessling; Yang Shi; Lorena Consolino; Gert Storm; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2021-06-15       Impact factor: 15.470

Review 10.  Noninvasive staging of liver fibrosis: review of current quantitative CT and MRI-based techniques.

Authors:  Won Hyeong Im; Ji Soo Song; Weon Jang
Journal:  Abdom Radiol (NY)       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.